167 related articles for article (PubMed ID: 7538513)
1. Levels of hepatitis C virus (HCV) RNA in serum and their relationship to levels of immunoglobulin M and G antibodies against HCV core protein.
Chen M; Sönnerborg A; Sällberg M
J Clin Microbiol; 1995 Mar; 33(3):778-80. PubMed ID: 7538513
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
[TBL] [Abstract][Full Text] [Related]
3. IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia.
L'Abbate A; Cutrupi S; Rognetta M; Fabiano C; Craxi A
Clin Exp Immunol; 1993 Nov; 94(2):313-6. PubMed ID: 7693384
[TBL] [Abstract][Full Text] [Related]
4. Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor?
Pawlotsky JM; Remire J; Darthuy F; Intrator L; Udin L; Dhumeaux D; Duval J
J Med Virol; 1995 Jan; 45(1):68-70. PubMed ID: 7536232
[TBL] [Abstract][Full Text] [Related]
5. HCV core IgM and IgG antibodies in blood donors.
Kapprell HP; Majnak A; Medgyesi GA; Szabó JE; Michel G; Albrecht M; Heyermann H; Hampl H; Troonen H
Vox Sang; 1995; 68(1):57-8. PubMed ID: 7536991
[No Abstract] [Full Text] [Related]
6. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus.
Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y
Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
[TBL] [Abstract][Full Text] [Related]
8. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR
J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
[TBL] [Abstract][Full Text] [Related]
9. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
10. Significance of IgM anti-HCV core level in chronic hepatitis C.
Papatheodoridis GV; Delladetsima JK; Katsoulidou A; Sypsa V; Albrecht M; Michel G; Hatzakis A; Tassopoulos NC
J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
[TBL] [Abstract][Full Text] [Related]
11. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection.
Lau GK; Lesniewski R; Johnson RG; Davis GL; Lau JY
J Med Virol; 1994 Sep; 44(1):1-4. PubMed ID: 7528259
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins.
Zhang ZX; Chen M; Sönnerborg A; Weiland O; Sällberg M
J Infect Dis; 1995 May; 171(5):1356-9. PubMed ID: 7538552
[TBL] [Abstract][Full Text] [Related]
14. IgM antibody response in acute hepatitis C viral infection.
Clemens JM; Taskar S; Chau K; Vallari D; Shih JW; Alter HJ; Schleicher JB; Mimms LT
Blood; 1992 Jan; 79(1):169-72. PubMed ID: 1309424
[TBL] [Abstract][Full Text] [Related]
15. IgG and IgM core antibodies and viral replication in hepatitis C virus carriers.
Yuki N; Hayashi N; Hagiwara H; Naito M; Ohkawa K; Katayama K; Kasahara A; Fusamoto H; Kamada T
J Hepatol; 1994 Jul; 21(1):110-4. PubMed ID: 7525692
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V
J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
[TBL] [Abstract][Full Text] [Related]
17. IgM antibody response to the hepatitis C virus core protein in intravenous drug users.
Toniutto P; Falleti E; Gasparini V; Fabris C; Tisminetzky SG; Lombardelli T; Pacco P; Satta A; Pirisi M
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):69-73. PubMed ID: 10091028
[TBL] [Abstract][Full Text] [Related]
18. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of an assay for hepatitis C virus core in the diagnosis of non-A, non-B hepatitis and monitoring of the response to interferon therapy.
Kawano S; Tanaka M; Fujiyama S; Sato S; Taura Y; Goto M; Chikazawa H; Sato T
J Gastroenterol Hepatol; 1994; 9(3):217-22. PubMed ID: 7519894
[TBL] [Abstract][Full Text] [Related]
20. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
Bååth L; Widell A
Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
[No Abstract] [Full Text] [Related]
[Next] [New Search]
